2003
DOI: 10.1007/s10038-003-0088-1
|View full text |Cite
|
Sign up to set email alerts
|

Cloning and mutation analysis of ZFP276 as a candidate tumor suppressor in breast cancer

Abstract: Loss of heterozygosity (LOH) involving chromosome 16q23.4 occurs frequently in breast tumors, which suggests that this region may contain a tumor suppressor gene. Since ZFP276 is located in this region, we have therefore cloned and performed mutation analysis of its coding region in 70 breast tumors. One silent polymorphism and two alterations predicted to result in amino acid changes were detected. Absence of the wild-type allele in tumors carrying the E530D variant suggests a possible role for this change in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
7
0
1

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 11 publications
1
7
0
1
Order By: Relevance
“…For example, the ZNF276 intronic variant rs12925026 is associated at genome-wide significance with nonmelanoma skin cancer (29). ZNF276 overlaps FANCA in a tail-to-tail manner (30). The genetically regulated predictor model for ZNF276 expression was fit using gene expression measured in GTEx breast tissues but neither this data set nor any of the other data sets could capture a predictor model for FANCA expression.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, the ZNF276 intronic variant rs12925026 is associated at genome-wide significance with nonmelanoma skin cancer (29). ZNF276 overlaps FANCA in a tail-to-tail manner (30). The genetically regulated predictor model for ZNF276 expression was fit using gene expression measured in GTEx breast tissues but neither this data set nor any of the other data sets could capture a predictor model for FANCA expression.…”
Section: Discussionmentioning
confidence: 99%
“…Several members of the FA family of proteins have been implicated in breast and ovarian cancer predisposition including, BRCA2 (FANCD1), BRIP1 (FANCJ), PALB2 (FANCN), and FANCM and it is possible that FANCA may represent another or possibly the true target breast cancer susceptibility gene in this region given this biological function and its overlap with ZNF276 (31,32). ZNF276 in its own right has also been implicated as a candidate tumor suppressor gene in breast cancer (30).…”
Section: Discussionmentioning
confidence: 99%
“…It is attractive to hypothesize that the rate-limiting step in vertebrate steroid hormone biosynthesis is also specifically regulated by unidentified transcriptional and/or splicing regulator(s). Whereas no apparent orthologs of ouib are found in vertebrates, their genomes possess a ZAD-ZFP gene called ZFP276 , which is a tumor suppressor gene [ 66 ]. Interestingly a ecd ortholog is also found in humans and may also contribute to the malignancy of certain tumor types [ 65 ].…”
Section: Discussionmentioning
confidence: 99%
“… 30 ZNF276 overlaps FANCA (MIM: 607139) in a tail-to-tail manner. 31 The genetically regulated predictor model for ZNF276 expression was fit using gene expression measured in GTEx breast tissues, but neither this dataset nor any of the other datasets could capture a predictor model for FANCA expression. FANCA encodes one of eight subunits that together form the core Fanconi Anemia (FA) complex that repairs blockages in DNA replication due to cross-linking.…”
Section: Discussionmentioning
confidence: 99%